MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 49 filers reported holding MERSANA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,220,000 | +15.7% | 480,644 | 0.0% | 0.00% | – |
| Q1 2022 | $1,918,000 | -93.9% | 480,644 | -90.4% | 0.00% | -100.0% |
| Q4 2021 | $31,207,000 | -44.9% | 5,017,078 | -16.5% | 0.01% | -50.0% |
| Q3 2021 | $56,650,000 | -39.3% | 6,007,375 | -12.6% | 0.01% | -37.5% |
| Q2 2021 | $93,395,000 | -6.6% | 6,877,336 | +11.3% | 0.02% | -11.1% |
| Q1 2021 | $99,957,000 | -19.3% | 6,177,793 | +32.8% | 0.02% | -21.7% |
| Q4 2020 | $123,818,000 | +75.4% | 4,653,066 | +22.7% | 0.02% | +53.3% |
| Q3 2020 | $70,585,000 | +4.5% | 3,790,832 | +31.3% | 0.02% | 0.0% |
| Q2 2020 | $67,534,000 | +54805.7% | 2,886,127 | +13619.3% | 0.02% | – |
| Q1 2020 | $123,000 | +1.7% | 21,037 | 0.0% | 0.00% | – |
| Q4 2019 | $121,000 | -91.2% | 21,037 | -97.6% | 0.00% | – |
| Q3 2019 | $1,372,000 | -62.4% | 867,916 | -3.8% | 0.00% | -100.0% |
| Q2 2019 | $3,653,000 | -28.1% | 901,938 | -6.6% | 0.00% | 0.0% |
| Q1 2019 | $5,080,000 | +28.8% | 965,732 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $3,944,000 | -85.6% | 966,902 | -64.6% | 0.00% | -83.3% |
| Q3 2018 | $27,303,000 | -43.9% | 2,730,395 | +0.3% | 0.01% | -45.5% |
| Q2 2018 | $48,630,000 | +4.5% | 2,722,927 | -7.7% | 0.01% | 0.0% |
| Q1 2018 | $46,526,000 | +17.1% | 2,950,341 | +22.0% | 0.01% | +22.2% |
| Q4 2017 | $39,734,000 | -3.9% | 2,418,324 | +1.1% | 0.01% | 0.0% |
| Q3 2017 | $41,348,000 | +46.3% | 2,391,404 | +16.8% | 0.01% | +28.6% |
| Q2 2017 | $28,270,000 | – | 2,047,344 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |